<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03356041</url>
  </required_header>
  <id_info>
    <org_study_id>Hawler Med University</org_study_id>
    <nct_id>NCT03356041</nct_id>
  </id_info>
  <brief_title>The Role of a Clinical Pharmacist in Lifestyle Modification in Type 2 Diabetic Patients With Peripheral Neuropathy</brief_title>
  <official_title>The Role of a Clinical Pharmacist in Lifestyle Modification</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hawler Medical University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hawler Medical University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aims of this study are to determine the prevalence of diabetic peripheral neuropathy
      among the diabetic patients, to determine the association between the clinical profiles of
      the diabetic patients (diabetes type, diabetes duration, HbA1c, body mass index,
      hypertension, total cholesterol) and the diabetic peripheral neuropathy DPN and the rational
      poly pharmacy used to control pain.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">December 20, 2017</start_date>
  <completion_date type="Anticipated">March 23, 2018</completion_date>
  <primary_completion_date type="Anticipated">March 16, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Double (Care Provider, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Estimating Summary of diabetes self-care activity (SDSCA)</measure>
    <time_frame>Three months</time_frame>
    <description>Assessing Lifestyle modification by summary of diabetes self-care activity (SDSCA) at baseline visit and after three months for both Intervention patients and usual care group Increases in the means of the items of the scale as Exercise, Blood sugar testing, Specific diet and Foot care in the intervention group.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Adherence to treatment according to Morisky scale</measure>
    <time_frame>Three months</time_frame>
    <description>Morisky scale is used to assess medication adherence at baseline visit and after three months for both Intervention patients and usual care group.
Improving the patient medication adherence behavior in the intervention group patients</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Douleur Neuropathique 4 (DN4), Neuropathic Pain Scale (NPS),</measure>
    <time_frame>Three months</time_frame>
    <description>Reduction in the percent of response of patients feeling; electric shock, tingling, and pin needle after the lifestyle modification in the intervention group.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Diabetic Peripheral Neuropathy</condition>
  <arm_group>
    <arm_group_label>Intervention Group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The intervention group will receive the three months' lifestyle modification program by a clinical pharmacist.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Usual care Group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>The usual care group will be provided the standard medical services</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Diabetic patients with neuropathy</intervention_name>
    <description>Lifestyle modification will be assessed using summary of diabetes self-care activity</description>
    <arm_group_label>Intervention Group</arm_group_label>
    <other_name>Intervention group</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion criteria

          1. Aged 18 years or older.

          2. Both sex.

          3. Diagnosed with type 2 diabetes at least one year previously.

          4. Took at least one prescribed medication for diabetes.

          5. Diagnosed as diabetic peripheral neuropathy based on clinical

        Exclusion Criteria:

          1. History of alcohol consumption.

          2. Thyroid gland disorder.

          3. Any kidney disorder.

          4. Any conditions that could confound assessment of pain due to diabetic peripheral
             neuropathy.

          5. Have foot injury or open sore.

          6. Pregnant females or who plan to become pregnant during the study period.

          7. Any serious medical condition that might prevent completion or hinder compliance with
             exercise.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Prof. Kawa Dizaye</name>
      <address>
        <city>Erbil</city>
        <country>Iraq</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kawa Dizaye, PhD</last_name>
      <phone>009647504452392</phone>
      <email>kawa.dizaye@hmu.edu.iq</email>
    </contact>
    <contact_backup>
      <last_name>Anfal Al-Mallah, MSc</last_name>
      <phone>009647702080031</phone>
      <email>anfalalmallah@gmail.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Iraq</country>
  </location_countries>
  <verification_date>November 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 17, 2017</study_first_submitted>
  <study_first_submitted_qc>November 22, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">November 29, 2017</study_first_posted>
  <last_update_submitted>November 22, 2017</last_update_submitted>
  <last_update_submitted_qc>November 22, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">November 29, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hawler Medical University</investigator_affiliation>
    <investigator_full_name>Kawa Dizaye</investigator_full_name>
    <investigator_title>Professor of Pharmacology</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Peripheral Nervous System Diseases</mesh_term>
    <mesh_term>Diabetic Neuropathies</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

